Editorial Comment to Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancer

被引：0
|
作者：
Yuasa, Takeshi [1 ]
机构：
[1] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2022年 / 29卷 / 01期
关键词：
MEN;
D O I：
10.1111/iju.14725
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer
    Park, Jong Chul
    Pratz, Caroline F.
    Tesfaye, Anteneh
    Brodsky, Robert A.
    Antonarakis, Emmanuel S.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 32 - 38
  • [32] The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer
    Wang, Zhipeng
    Zhu, Sha
    Zhao, Jinge
    Nie, Ling
    Chen, Xueqin
    Zhang, Mengni
    Chen, Ni
    Sun, Guangxi
    Chen, Junru
    Ni, Yuchao
    Dai, Jindong
    Liu, Zhenhua
    Tao, Ronggui
    Zhang, Xingming
    Zhu, Xudong
    Zhang, Haoran
    Liang, Jiayu
    Wang, Zilin
    He, Ben
    Shen, Pengfei
    Zeng, Hao
    PROSTATE, 2021, 81 (15): : 1191 - 1201
  • [33] Serum testosterone level and overall survival in first-line abiraterone and enzalutamide for metastatic castration-resistant prostate cancer patients.
    Silveira Vilbert, Maysa Tamara
    Cesca, Marcelle Goldner
    Pandolfi, Natasha Carvalho
    Calsavara, Vinicius Fernando
    de Mendonca Uchoa, Bruno Cezar
    de Andrade, Poliana
    Coelho, Ricardo Lima
    Corassa, Marcelo
    Rinck, Jose A.
    Dettino, Aldo A.
    Oliveira, Thiago Bueno
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    dos Reis, Rodolfo Borges
    Muglia, Valdair
    Faria, Eliney F.
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 612 - 613
  • [35] Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818).
    Maluf, Fernando Cotait
    S. Martins, Suelen P.
    Vieira Silva Neto, Deusdedit Cortez
    Werutsky, Gustavo
    Rinck, Jose Augusto, Jr.
    Bastos, Diogo Assed
    Rocha, Roberto Odebrecht
    Fernandes, Roni de Carvalho
    Girardi, Daniel da Motta
    Araujo, Daniel Vilarim
    Mota, Augusto C. A.
    Lara Gongora, Aline Bobato
    Fernandes, Bruno Melo
    Fonseca Alves, Ana Caroline
    Anjos Tavares Sampaio, Cristina de Deus
    Ponte de Souza, Andrea Lopes
    de Jesus, Rafaela Gomes
    de Lima Gossling, Gustavo Cartaxo
    Soares, Andrey
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [36] Association of body composition with survival and efficacy of first-line treatment in patients with castration-resistant prostate cancer
    Joung, Jae Young
    Pak, Sahyun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
    Zhao, Jinge
    Shen, Pengfei
    Sun, Guangxi
    Chen, Ni
    Liu, Jiandong
    Tang, Xin
    Huang, Rui
    Cai, Diming
    Gong, Jing
    Zhang, Xingming
    Chen, Zhibin
    Li, Xiang
    Wei, Qiang
    Zhang, Peng
    Liu, Zhenhua
    Liu, Jiyan
    Zeng, Hao
    ONCOTARGET, 2017, 8 (33) : 55374 - 55383
  • [38] First-line Therapy for Metastatic Castration-sensitive Prostate Cancer
    Lau, Y. H.
    Wan, L. Y.
    Lam, M. H. C.
    HONG KONG JOURNAL OF RADIOLOGY, 2022, 25 (03): : 244 - 245
  • [39] Effect of neuroendocrine differentiation on therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.
    Xu, Nanwei
    Zhao, Jinge
    Shen, Pengfei
    Chen, Ni
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [40] Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
    Kaye, Deborah R.
    Khilfeh, Ibrahim
    Muser, Erik
    Morrison, Laura
    Kinkead, Frederic
    Urosevic, Ana
    Lefebvre, Patrick
    Pilon, Dominic
    George, Daniel J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 201 - 214
12345